Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
If you are newly diagnosed or have relapsed you must think how to maintain bone health for the rest of your life. The content linked and excerpted below cites both conventional bisphosphonate therapies such as Zometa and Pamidronate and evidence-based non-conventional therapies such as magnesium and weight-bearing exercise.
Further, it is common to present with a compression fracture, usually in your spine. The issue then is how best to stabilize the bone damage. I’ve read testimonials from mm patients who think kyphoplasty is great. However, the second study below cites the ability for bones to heal on their own.
I’ve never found research that finds for one therapy or the other.
Please consider combining current standard-of-care bone therapy, bisphosphonates, with evidence-based, non-conventional bone health therapies such vitamin D3. The final paragraph linked below explains average costs for standard-of-care bone health therapies. When I was undergoing active therapies I focused on chemotherapy regimens- what was working, what side effects occurred, those sorts of issues. I didn’t focus on the high cost of bone therapies… big mistake.
Recommended for patients with or without evidence of lytic damage
“Patients with symptomatic multiple myeloma should receive bone-modifying therapy irrespective of evidence of lytic destruction or spinal compression fracture, according to an updated guideline from the American Society of Clinical Oncology (ASCO).
Treatment options consist of the intravenous bisphosphonates pamidronate and zoledronic acid (Zometa) or, alternatively, the RANK ligand inhibitor denosumab (Xgeva). Denosumab might be preferred over zoledronic acid for patients with renal impairment, as the RANKL inhibitor has been associated with fewer renal adverse events...
“These recommendations are consistent with the previous recommendations, with new information on denosumab,” the guideline authors stated. “Additional modifications were made to some of the recommendations on the basis of recent data to better clarify the indications for treatment, duration of treatment, and associated complications of treatment…”
The updated guideline also includes a table with the estimated cost of bone-modifying agents. Pamidronate and zoledronic acid had per-dose costs of $30.67 and $53.64, respectively, whereas each dose of denosumab cost $1,995.48. The estimated 1-year costs were $398.71 for pamidronate, $214.56 for zoledronic acid administered every 12 weeks, $697.37 for zoledronic acid every 4 weeks, and $25,9341.24 for denosumab every 4 weeks...”
“You’ve got a few key treatment goals when you have a compression fracture of the spine. You want to ease the pain, heal the fracture, and treat the osteoporosis that weakened your bones and caused them to collapse.
There’s a good chance you won’t need surgery. Most people can get by without it. Compression fractures usually heal on their own in about 3 months. While that happens, your doctor may suggest you try some things at home that can make you feel better, such as pain medicines, rest, physical therapy, or a back brace…
Once you’re feeling better, ask your doctor if you should join a rehab program or work with a physical therapist. Exercises that strengthen your back can help you avoid having more compression fractures.
Check with your doctor about the best weight-bearing exercises for you, such as:
[…] Multiple Myeloma Bone Health- Conventional and Non-conventional […]Reply